OLYMPIA, Wash., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Green Hygienics Holding Inc. (OTCBB:GRYN) updates shareholders on the company's opportunity in Washington State, the fastest growing legal Cannabis market in the USA.
Green Hygienics has met with dozens of potential partners in Colorado, California and Washington State in the past six months. The Company's mandate is to find aggressive well capitalised partners in states where marijuana has been legalised for recreational use. Green Hygienics is pleased to report that the company has been in discussions for the past month with a Washington State private company that is seeking a partner that has expertise in designing, building and managing state of the art cannabis production facilities. The opportunity is to execute over 200,000 square feet of production facilities with phase one being 30,000 square feet.
Green Hygienics CEO Rick Powell stated, "We are very excited at the scope of this project as well as the quality of our potential partners. Washington State has done an excellent job rolling out their regulations and provides a risk free environment for this fast growing market. We are happy to have the opportunity to be part of it."
The company will continue to update shareholders as negotiations advance.
ABOUT GREEN HYGIENICS
Green Hygienics is a large scale, turn-key commercial indoor cultivation company, providing, design, engineering, construction and management services for the commercial cannabis industry in the United States and Canada. The company's sterile growing environment boasts the highest Quality Assurance standards with the most control. It's proprietary, soilless, scalable production system is the highest yielding, lowest running cost method available in the industry. This produces the highest quality and most consistent product while maintaining the lowest carbon footprint.
Safe Harbor Statements
Certain information contained in this news release constitutes "forward-looking statements" as such term is used in applicable United States and Canadian laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "expects" or "does not expect," "is expected," "anticipates" or "does not anticipate," "plans," "estimates," "intends" or "believes," or that certain actions, events or results "may," "could," "would," "might" or "will be taken," "occur," or "be achieved." Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these factors are beyond the Company's ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company's filings with the SEC. Such risks and other factors include, among others, the ability to locate and acquire suitable interests in alternative medicine manufacturing operations on terms acceptable to the Company, the availability of financing on acceptable terms, accidents, labor disputes, acts of God and other risks of the alternative medicine industry including, without limitation, delays in obtaining governmental approvals or permits, title disputes or claims limitations on insurance coverage. The Company believes that the expectations reflected in the forward-looking statements included in this news release are reasonable; however, no assurance can be given that these expectations will prove to be correct, and such forward-looking statements should not be unduly relied upon. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.